Key terms

About XRAY

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest XRAY news

Mar 27 5:26pm ET Dentsply Sirona to replace Fox Factory in S&P 400 at open on 4/3 Mar 27 5:23pm ET GE Vernova to replace Dentsply Sirona in S&P 500 at open on 4/2 Mar 05 1:31am ET Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX), DENTSPLY SIRONA (XRAY) and Karuna Therapeutics (KRTX) Mar 01 10:15am ET Maintaining Buy Rating on DENTSPLY SIRONA: A Comprehensive Analysis of Strong Q4 Performance and Positive Fiscal Outlook Mar 01 8:36am ET DENTSPLY SIRONA: A Strong Buy on Impressive Q4 Performance and Strategic Market Positioning Mar 01 8:20am ET Analysts Conflicted on These Healthcare Names: DENTSPLY SIRONA (XRAY), Xenon (XENE) and Oric Pharmaceuticals (ORIC) Mar 01 1:10am ET DENTSPLY SIRONA: A Buy Rating Amid Dental Downturn, Outperforming with Strong Q4 Results and Promising FY24 Guidance Feb 29 1:20pm ET Analysts Offer Insights on Healthcare Companies: Theratechnologies (THTX), MoonLake Immunotherapeutics (MLTX) and DENTSPLY SIRONA (XRAY) Feb 29 9:00am ET Analysts Conflicted on These Healthcare Names: Castle Biosciences (CSTL), DENTSPLY SIRONA (XRAY) and Silk Road Medical (SILK) Feb 29 7:43am ET DENTSPLY SIRONA Announces Board Member’s Upcoming Departure Feb 29 6:01am ET Dentsply Sirona sees FY24 adjusted EPS $2.00-$2.10, consensus $2.05 Feb 29 6:00am ET Dentsply Sirona reports Q4 adjusted EPS 44c, consensus 43c Feb 28 8:25pm ET Notable companies reporting before tomorrow’s open Feb 28 1:04pm ET Notable companies reporting before tomorrow’s open Feb 26 7:55am ET Piper Sandler Sticks to Their Hold Rating for DENTSPLY SIRONA (XRAY) Feb 26 6:27am ET Dentsply Sirona initiated with an Outperform at Leerink Jan 26 7:42am ET Dentsply Sirona price target raised to $35 from $32 at Stifel Jan 12 7:37am ET Piper Sandler Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY) Jan 12 7:24am ET Dentsply Sirona price target raised to $35 from $31 at Piper Sandler Jan 10 5:37am ET DENTSPLY SIRONA: Hold Rating with Cautious Optimism Amid Macroeconomic Uncertainty Jan 09 10:35am ET Upgraded Price Target and Buy Rating for DENTSPLY SIRONA Amid Positive 2023 Revenue and EPS Growth Prospects Jan 09 8:37am ET Dentsply Sirona sees double-digit adjusted EPS growth in 2024 Jan 09 8:36am ET Dentsply Sirona sees 2023 adjusted EPS $1.80-$1.85, consensus $1.82

No recent news articles are available for XRAY

No recent press releases are available for XRAY

XRAY Financials

1-year income & revenue

Key terms

XRAY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

XRAY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms